Supply Chain

Sales representatives for medical device companies have been attending surgeries for years, but hospital leaders may start to take a closer look at whether these reps should be in the operating room, according to NPR.  

The FDA plans to revamp how it clears medical devices through an expedited approval process called the 510(k) pathway, FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director of the Center for Devices and Radiological Health, announced in a…

Pear Therapeutics and Novartis division Sandoz launched reSET, a digital therapeutic for substance use disorder, Nov. 19.

The FDA has proposed a new plan to regulate digital tools developed by pharmaceutical companies, such as apps that offer medication reminders.

After collecting 21,000 fewer donations than hospitals needed, the American Red Cross is facing a severe blood shortage, according to The Herald News.

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

Boston Scientific, a medical devicemaker, plans to shed $150 million in expenses annually over the next three years, which may include "limited" layoffs, according to the Boston Business Journal.

We recently surveyed more than 400 hospital staff, including nurses, physicians, service line leaders and supply chain administrators, to understand how the supply chain affected their day-to-day work. We learned that these colleagues shared some fundamental goals, but each held…

Here are four drugs or medical devices that have been approved by the FDA since Nov. 9:

Seventy-three percent of hospital leaders consider value-based contracting with suppliers a priority for improving return on investment, but opportunities for these types of contracts lag, according to a recent Premier survey.